Catecholaminergic Polymorphic Ventricular Tachycardia

• CLINICAL_TRIALS research · 2026-03-27
  Clinical Trial Update: A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) [Phase 1]

  A Phase 1 clinical trial evaluating the SGT-501 gene therapy for catecholaminergic polymorphic ventricular tachycardia is currently recruiti…

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: A Phase 2 Study of CRD-4730 in CPVT [Phase 2]

  A Phase 2 clinical trial evaluating CRD-4730 for catecholaminergic polymorphic ventricular tachycardia is currently recruiting.

• CLINICAL_TRIALS research · 2026-01-16
  Clinical Trial Update: Derivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias

  This clinical trial update notes enrollment by invitation for a Johns Hopkins study deriving human induced pluripotent stem cells to model h…

• CLINICAL_TRIALS research · 2025-12-26
  Clinical Trial Update: Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) [Phase 2]

  This Phase 2 clinical trial is assessing safety, tolerability, and exploratory efficacy of AGP100 in patients with Catecholaminergic Polymor…

• CLINICAL_TRIALS research · 2025-05-31
  Clinical Trial Update: Evaluation of Exercise Testing and Physical Activity in Children and Adolescents Living With Inherited Arrhythmias

  This clinical trial update notes ongoing recruitment for a study evaluating exercise testing and physical activity in children and adolescen…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.